EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Efficacy of Prophylactic Tranexamic Acid Use After Vaginal Delivery According to Postpartum Hemorrhage Risk: Randomized, Double‐Blind, Placebo‐Controlled Trial

Oznur Tosun, Nefise Nazlı Yenigul iD, Elif Yüce Bilgin iD, Burcu Dincgez iD

Journal of Obstetrics and Gynaecology Research · 2026-06 · 52 (6)

DOI: 10.1111/jog.70372 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Obstetrics and Gynaecology Research, online erschienen am 15.06.2026. Verfasst von Oznur Tosun und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Antalya City Hospital, Antalya, Turkey. Hauptthemen laut MEDLINE: Antifibrinolytic Agents, Delivery, Obstetric, Postpartum Hemorrhage, Tranexamic Acid. Die Arbeit nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Postpartum hemorrhage (PPH) remains a major cause of maternal morbidity despite standard active management of the third stage of labor. Evidence regarding the prophylactic use of tranexamic acid (TA) after vaginal delivery, particularly according to PPH risk stratification, is limited. This study aimed to evaluate the efficacy of prophylactic intravenous tranexamic acid administered after vaginal delivery in reducing postpartum blood loss. The primary outcome was measured blood loss during the third and fourth stages of labor. Secondary outcomes included the incidence of uterine atony, need for blood transfusion, requirement for additional uterotonics, and treatment‐related adverse effects, assessed separately in low‐ and high‐risk PPH groups. Materials and Methods This double‐blind, prospective, randomized controlled trial included 480 singleton pregnant women aged 18–45 years who delivered at ≥ 34 weeks of gestation. Participants were first stratified according to postpartum hemorrhage (PPH) risk as low‐risk ( n = 240) or high‐risk ( n = 240). Within each risk group, women were randomly assigned in a 1:1 ratio to receive either intravenous tranexamic acid (1 g) or placebo after vaginal delivery (120 participants per treatment arm in each risk group).

Results

In low‐risk patients, both the collected blood volume and estimated blood loss were significantly lower in the tranexamic acid (TA) group compared with placebo. In high‐risk patients, TA administration was associated with significantly reduced collected blood volume and estimated blood loss, as well as a lower incidence of uterine atony. In addition, the need for blood transfusion and additional uterotonic use was lower in patients receiving TA, particularly in the high‐risk group. No clinically significant differences were observed in laboratory safety parameters, including D‐dimer levels.

Conclusion

Prophylactic tranexamic acid administration after vaginal delivery significantly reduced postpartum blood loss compared with placebo. While TA was effective in reducing blood loss in both low‐ and high‐risk patients, a significant reduction in uterine atony was observed only in the high‐risk group. No major adverse effects related to TA were identified, suggesting that TA was well tolerated in the study population. Major maternal morbidity outcomes were not assessed in this study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifibrinolytic AgentsDelivery, ObstetricPostpartum HemorrhageTranexamic AcidAdultFemaleHumansPregnancyYoung AdultDouble-Blind Method

Stichwörter der Autor:innen

active management of vaginal deliverypostpartum hemorrhage tranexamic acidvaginal delivery

Substanzen

Antifibrinolytic AgentsTranexamic Acid

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Antalya City Hospital, Antalya, Turkey.
  • Department of Obstetrics and Gynecology, Acıbadem Bursa Hospital, Bursa, Turkey.
  • Department of Obstetrics and Gynecology, Başakşehir Çam Ve Sakura City Hospital, İstanbul, Turkey.
  • Department of Obstetrics and Gynecology, University of Health Sciences School of Medicine Bursa Yuksek Ihtisas Research and Training Hospital, Bursa, Turkey.

ORCID-Profile: Nefise Nazlı Yenigul, Elif Yüce Bilgin, Burcu Dincgez

Zitieren

APA

Tosun, O., Yenigul, N. N., Bilgin, E. Y., & Dincgez, B. (2026). Efficacy of Prophylactic Tranexamic Acid Use After Vaginal Delivery According to Postpartum Hemorrhage Risk: Randomized, Double‐Blind, Placebo‐Controlled Trial. Journal of Obstetrics and Gynaecology Research, 52(6). https://doi.org/10.1111/jog.70372

Vancouver

Tosun O, Yenigul NN, Bilgin EY, Dincgez B. Efficacy of Prophylactic Tranexamic Acid Use After Vaginal Delivery According to Postpartum Hemorrhage Risk: Randomized, Double‐Blind, Placebo‐Controlled Trial. Journal of Obstetrics and Gynaecology Research. 2026;52(6). doi:10.1111/jog.70372

BibTeX
@article{Tosun2026,
  author = {Tosun, Oznur and Yenigul, Nefise Nazlı and Bilgin, Elif Yüce and Dincgez, Burcu},
  title = {Efficacy of Prophylactic Tranexamic Acid Use After Vaginal Delivery According to Postpartum Hemorrhage Risk: Randomized, Double‐Blind, Placebo‐Controlled Trial},
  journal = {Journal of Obstetrics and Gynaecology Research},
  year = {2026},
  volume = {52},
  number = {6},
  doi = {10.1111/jog.70372}
}
Kostenlos starten →